$142.88
1.59% today
Nasdaq, Apr 02, 09:18 pm CET
ISIN
US6323071042
Symbol
NTRA
Sector
Industry

Natera, Inc. Stock price

$140.65
-2.46 1.72% 1M
+13.46 10.58% 6M
-17.65 11.15% YTD
+47.69 51.30% 1Y
+97.75 227.86% 3Y
+114.29 433.57% 5Y
+117.91 518.51% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
-0.76 0.54%
ISIN
US6323071042
Symbol
NTRA
Sector
Industry

Key metrics

Market capitalization $19.01b
Enterprise Value $18.23b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 263.33
EV/Sales (TTM) EV/Sales 10.74
P/S ratio (TTM) P/S ratio 11.21
P/B ratio (TTM) P/B ratio 15.61
Revenue growth (TTM) Revenue growth 56.75%
Revenue (TTM) Revenue $1.70b
EBIT (operating result TTM) EBIT $-222.29m
Free Cash Flow (TTM) Free Cash Flow $69.24m
Cash position $968.28m
EPS (TTM) EPS $-1.53
P/E forward negative
P/S forward 9.90
EV/Sales forward 9.49
Short interest 2.98%
Show more

Is Natera, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Natera, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Natera, Inc. forecast:

22x Buy
96%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a Natera, Inc. forecast:

Buy
96%
Sell
4%

Financial data from Natera, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,697 1,697
57% 57%
100%
- Direct Costs 674 674
14% 14%
40%
1,023 1,023
108% 108%
60%
- Selling and Administrative Expenses 807 807
39% 39%
48%
- Research and Development Expense 404 404
26% 26%
24%
-188 -188
54% 54%
-11%
- Depreciation and Amortization 35 35
11% 11%
2%
EBIT (Operating Income) EBIT -222 -222
50% 50%
-13%
Net Profit -190 -190
56% 56%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Natera, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Natera, Inc. Stock News

Neutral
Business Wire
8 days ago
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025. DEFINE-HT is the first prospective, multicenter study in heart transplan...
Neutral
The Motley Fool
14 days ago
Stanley Druckenmiller, whose net worth is around $6.9 billion, made most of his fortune as a hedge fund manager, and became a well-known name on Wall Street while working for George Soros until 2000.
Positive
Seeking Alpha
16 days ago
Natera Inc. shows robust growth with high margins, a strong genetic testing portfolio, and a recent pullback offering an attractive entry point for investors.
More Natera, Inc. News

Company Profile

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Head office United States
CEO Stephen Chapman
Employees 4,434
Founded 2004
Website www.natera.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today